Atrovent and Autoimmune hepatitis - a phase IV clinical study of FDA data

Summary:

Autoimmune hepatitis is reported as a side effect among people who take Atrovent (ipratropium bromide), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Albuterol, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Autoimmune hepatitis when taking Atrovent. It is created by eHealthMe based on reports of 33,026 people who have side effects when taking Atrovent from the FDA, and is updated regularly.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

What is Autoimmune hepatitis?

Autoimmune hepatitis is found to be associated with 580 drugs and 820 conditions by eHealthMe. Check the latest studies of Autoimmune hepatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

33,026 people reported to have side effects when taking Atrovent.
Among them, 13 people (0.04%) have Autoimmune hepatitis.

Could Atrovent cause Autoimmune hepatitis?

Among these 13 people:

How long have people been on Atrovent when they have Autoimmune hepatitis? *

What is the gender of people who have Autoimmune hepatitis when taking Atrovent? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Autoimmune hepatitis when taking Atrovent? *

What are other drugs people take besides Atrovent? *

What are other side effects people have besides Autoimmune hepatitis? *

Fatigue (feeling of tiredness): 5 people, 38.46%
Fever: 5 people, 38.46%
Liver Function Tests Nos Abnormal: 5 people, 38.46%
Weakness: 4 people, 30.77%
Nausea (feeling of having an urge to vomit): 4 people, 30.77%
Hepatomegaly (abnormal enlargement of the liver): 4 people, 30.77%
Weight Decreased: 3 people, 23.08%
Joint Pain: 3 people, 23.08%
Cytomegalovirus Infection: 3 people, 23.08%
Oesophageal Reflux (moving the food downwards): 3 people, 23.08%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 4 people, 30.77%
Pneumonia: 1 person, 7.69%
Neck Pain: 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 7.69%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 7.69%
Hypokalemia (low potassium): 1 person, 7.69%
Headache (pain in head): 1 person, 7.69%
General Physical Health Deterioration (weak health status): 1 person, 7.69%
Fever: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and have Autoimmune hepatitis?

- Check whether Autoimmune hepatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atrovent:

Atrovent (33,210 reports)

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Autoimmune hepatitis:

Autoimmune hepatitis (580 drugs)

Browse all the conditions that are associated with Autoimmune hepatitis:

Autoimmune hepatitis (820 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide (the active ingredients of Atrovent) and Atrovent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.